Cell cycle inhibitory protein p27 in human middle ear cholesteatoma

ORL

Volumn 68, Issue 5, 2006, Pages 296-301

  Kuczkowski, Jerzy ^a   Bakowska, Alicja ^a   Pawelczyk, Tadeusz ^a   Narozny, Waldemar ^a   Mikaszewski, Boguslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Cholesteatoma; Cyclin dependent kinase inhibitor

Indexed keywords

PROTEIN P27;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE; CHILD; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; STAINING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA, MIDDLE EAR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; EAR CANAL; EPITHELIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 33748448863     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094377     Document Type: Article

References (16)

1. Albino AP, Kimmelman CP, Parisier SC: Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7-19.
2. Bujia J, Holly A, Schilling V, et al: Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993;103:326-329.
3. Albino AP, Reed JA, Bogdany JK, Sassoon J, Desloge RB, Parisier SC: Expression of p53 protein in human middle ear cholesteatomas. Pathogenetic implications. Am J Otol 1998;19:30-36.
4. Bujia J, Schilling V, Holly A, Stammberger M, Kastenbauer E: Hyperproliferation-associated keratin expression in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993;113:364-368.
5. Kip1 and Ki-67 in cholesteatoma epithelium. Laryngoscope 2000;110:1898-1901.
6. Tanaka Y, Kojima H, Miyazaki H, Koga T, Moriyama H: Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium. Laryngoscope 1999;109:1102-1107.
7. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994;78:59-66.
8. Shinoda H, Huang C: Expression of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation and programmed cell death. Laryngoscope 1995;105:1232-1237.
9. Kip1 in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. J Clin Invest 1999;104:815-823.
10. Meyerson M, Harlow E: Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994;14:2077-2086.
11. Laemmli U: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. Kip1 (KIP1), is associated with cholesteatoma. Laryngoscope 2001;111:1037-1041.
14. Kojima H, Tanaka Y, Tanaka T, et al: Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 1998;124:261-264.
15. Choufani G, Mahillon V, Decaestecker C, et al: Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 1999;109:1824-1831.
16. Ohashi Y, Sasano H, Yamaki H: Cell cycle inhibitory protein p27 in esophageal squamous cell carcinoma. Anticancer Res 1999;19:1843-1848.